Ovarian Cancer Awareness — Listen to the Small Signs. Protect Your Tomorrow. Early symptoms include bloating, early fullness, pelvic discomfort and urinary changes.

Small symptoms. Timely evaluation. Better outcomes.

Many women in Kolkata live with bloating, lower abdominal discomfort, or a feeling of fullness after eating and assume it is gas, acidity, or a minor digestive issue. In most cases, these symptoms do have simple causes. But when they keep returning — when they are new, persistent, and present almost daily for more than two to three weeks — they should be taken seriously and evaluated by a doctor.

Ovarian cancer is difficult to notice early because its symptoms are mild, vague, and easily mistaken for something else. This is not a reason for alarm. It is a reason for awareness.

Why Ovarian Cancer Is Often Missed

Ovarian cancer is often missed because there is no approved routine screening test for women at average risk. The ovaries sit deep in the pelvis, so tumours can grow large before causing symptoms. Neither the CA-125 blood test nor transvaginal ultrasound is accurate enough for population-wide screening. As a result, most ovarian cancer in India is diagnosed at an advanced stage.

The ovaries sit deep inside the pelvis. A tumour growing on or within them can reach a significant size before it causes any noticeable discomfort. Unlike breast or cervical cancer, there is no approved routine screening test for ovarian cancer for women at average risk — no equivalent of a mammogram or a Pap smear that can be used across the general population.

This is not because researchers have not tried. It is because the tests available — the CA-125 blood test and transvaginal ultrasound — are simply not accurate enough to be used as routine screening tools. CA-125 can be normal in early cancer, and it can also be elevated in entirely benign conditions. Ultrasound can detect a mass, but cannot confirm whether it is cancerous. Major medical organisations worldwide do not recommend either test for routine screening in women without symptoms.

"A normal CA-125 or a normal ultrasound is not reassurance if you have persistent symptoms. When symptoms are present, they need evaluation — regardless of these test results."

The result of all this is that more than 70% of ovarian cancer cases in India are diagnosed at an advanced stage, when treatment is more difficult and survival rates fall sharply.[1] When detected at Stage I, the five-year survival rate exceeds 90%. At Stage III or IV, that figure drops to between 20 and 30%.[2]

The gap between these two numbers is, in most cases, the difference between a curable disease and a very difficult one. And the gap is closeable — through awareness.

Cancer Type Most Common Symptom Key Risk Factor Routine Screening
Cervical Abnormal bleeding or discharge HPV infection Yes — Pap smear + HPV test
Ovarian Persistent bloating or fullness BRCA mutation, family history No routine screening
Uterine Post-menopausal bleeding Obesity, diabetes, PCOS No routine screening
Vulval Persistent itch or lump HPV, lichen sclerosus No routine screening

Gynaecological cancers at a glance — symptoms, risk factors, and screening availability

Symptoms That Deserve Medical Attention

Symptoms needing evaluation include persistent bloating, feeling full quickly after small meals, pelvic or lower abdominal pain, frequent urination, changes in bowel habits, unexplained fatigue, lower back pain, unexplained weight loss, and abdominal swelling. The key factor is persistence — symptoms that are new, occur almost daily, and last more than two to three weeks without an obvious cause.

These symptoms are not specific to ovarian cancer. But if they are new, persistent, and happening almost daily for more than two to three weeks — without an obvious cause — they should be evaluated:

Do not manage these symptoms repeatedly with antacids or self-medication for gas and acidity. If they persist for more than two to three weeks, see a doctor — not to confirm cancer, but to rule it out properly.

Who May Be at Higher Risk

Higher risk for ovarian cancer is associated with a first-degree relative with ovarian cancer, a strong family history of breast cancer, BRCA1 or BRCA2 gene mutations, Lynch syndrome, endometriosis, never having been pregnant, and early periods or late menopause. Higher risk does not mean cancer will develop — it means symptoms deserve earlier discussion with a doctor.

Ovarian cancer can affect any woman, but certain factors are known to increase risk. Higher risk does not mean cancer will definitely develop — it means symptoms should be taken more seriously and discussed with a doctor earlier.

If you have a first-degree relative with ovarian cancer, or a strong family history of breast cancer, discuss the possibility of genetic testing with your doctor. Knowing your risk allows for appropriate and timely decision-making.

How Ovarian Cancer Is Evaluated

Evaluation for suspected ovarian cancer typically includes a transvaginal ultrasound to detect a mass, a CA-125 blood test alongside imaging (not alone), and a CT scan to check for spread beyond the ovary. Unlike most cancers, ovarian cancer is usually confirmed and staged through surgery itself, which also serves as the first step of treatment.

Because there is no reliable screening test, evaluation begins with symptoms prompting investigation. If ovarian cancer is suspected, a doctor may advise one or more of the following:

If there is a concern for cancer based on symptoms, imaging, or blood tests, the right specialist is a Gynaecological Oncologist — a doctor specifically trained in cancers of the female reproductive organs.

Treatment: What It Involves

Ovarian cancer treatment centres on surgery to remove the uterus, ovaries, fallopian tubes, and omentum, aiming to remove as much tumour as possible. Chemotherapy, usually carboplatin and paclitaxel, typically follows surgery, or precedes it in advanced cases. HIPEC may be used in selected advanced cases at specialist centres. Fertility-sparing surgery is an option for carefully selected young women with early-stage disease.

Treatment depends on the stage, type, and individual clinical circumstances. It may include:

The treatment plan is always decided by the specialist based on the individual — the stage, the type of cancer, the patient's overall health, and their personal circumstances.

Stage Description 5-Year Survival Rate
Stage I Cancer confined to one or both ovaries Over 90%
Stage II Spread within the pelvis Approximately 70%
Stage III Spread to the abdominal lining or lymph nodes 29–40%
Stage IV Spread to distant organs (liver, lungs, spleen) Approximately 20%

Five-year survival rates by stage at diagnosis. Source: National Cancer Grid India / SEER Database.[2]

Frequently Asked Questions

What are the early symptoms of ovarian cancer?
Persistent bloating, feeling full very quickly after eating, pelvic or lower abdominal pain, frequent urination, changes in bowel habits, unexplained fatigue, lower back pain, and abdominal swelling. The key word is persistent — symptoms that are new, occur almost daily, and do not resolve after two to three weeks without an obvious explanation should be evaluated.
Can ultrasound detect ovarian cancer?
Ultrasound can detect a mass or cyst on the ovary, but it cannot confirm whether the finding is cancerous or benign on its own. It is a useful first-line investigation but must be interpreted alongside other tests and clinical findings.
Is CA-125 a reliable screening test for ovarian cancer?
No. CA-125 is not recommended as a routine screening test for women without symptoms. It can be normal even in early cancer, and it can also be elevated in benign conditions such as endometriosis, fibroids, and pelvic inflammatory disease. It is most useful for monitoring response to treatment in women already diagnosed.
Which doctor should I consult in Kolkata?
Start with a gynaecologist. If there is a concern for cancer based on symptoms, imaging, or blood tests, a Gynaecological Oncologist is the appropriate specialist — trained specifically in cancers of the female reproductive organs, including ovarian cancer.
Can young women get ovarian cancer?
Yes. While most cases occur after the age of 50, certain types — particularly germ cell tumours — tend to affect younger women and adolescents. Persistent pelvic symptoms in a young woman should not be dismissed on the assumption that ovarian cancer only affects older women.
Does every ovarian cyst mean cancer?
No. Ovarian cysts are very common and the vast majority are benign. A simple cyst in a premenopausal woman is usually monitored rather than immediately treated. What distinguishes a concerning finding is its characteristics on imaging — whether it is solid, complex, or associated with an elevated CA-125 — all of which require specialist evaluation.
Is ovarian cancer treatable?
Yes, and outcomes are strongly linked to the stage at diagnosis. When detected at Stage I, the five-year survival rate exceeds 90%. This drops significantly at advanced stages — which is where the majority of cases in India are currently found. Early evaluation when symptoms are persistent is the single most important step a woman can take.

A Final Note

Ovarian cancer does not begin with dramatic symptoms. It begins with small, persistent changes — in appetite, in the way the abdomen feels, in bladder habits, in energy levels. These changes, when they last more than two to three weeks without explanation, deserve evaluation.

For women in Kolkata, the message is straightforward: if bloating, pelvic discomfort, early fullness, or urinary changes continue for weeks and do not have an obvious cause, see a doctor. Not because these symptoms confirm cancer — they almost certainly do not — but because early evaluation is always simpler, safer, and more effective than delayed evaluation.

Awareness today. Stronger women tomorrow.

References

  1. GLOBOCAN 2022. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer, World Health Organization. gco.iarc.fr
  2. National Cancer Grid India. NCG Guidelines for Ovarian Cancer. Tata Memorial Centre, 2024. tmc.gov.in
  3. Kuchenbaecker KB, Hopper JL, Barnes DR et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402–2416. doi:10.1001/jama.2017.7112
Dr. Dipanwita Banerjee — Gynaecological Oncologist, CNCI Kolkata
Dr. Dipanwita Banerjee
MCh (Gynaecological Oncology) · AIIMS New Delhi · IFCPC IARC Certified Colposcopist
Senior Consultant Gynaecological Oncologist at Chittaranjan National Cancer Institute (CNCI), Kolkata. Specialising in complex gynaecological cancer surgeries, robotic surgery, HIPEC, and the comprehensive management of ovarian, uterine, and cervical malignancies.

Have symptoms that need evaluation?

Dr. Dipanwita Banerjee offers consultations at CNCI Kolkata for ovarian, uterine, and cervical cancer evaluation and treatment.

Book a Consultation